CM
PRTK
CM Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-250,000
| Closed | -$553K | – | 74 |
|
|
2023
Q2 | $553K | Sell |
250,000
-200,000
| -44% | -$442K | 0.54% | 51 |
|
|
2023
Q1 | $1.14M | Buy |
450,000
+105,000
| +30% | +$267K | 1.36% | 30 |
|
|
2022
Q4 | $645K | Sell |
345,000
-55,000
| -14% | -$103K | 0.77% | 45 |
|
|
2022
Q3 | $1.03M | Buy |
400,000
+50,000
| +14% | +$129K | 1.15% | 31 |
|
|
2022
Q2 | $676K | Hold |
350,000
| – | – | 0.72% | 46 |
|
|
2022
Q1 | $1.04M | Buy |
350,000
+50,000
| +17% | +$149K | 0.87% | 40 |
|
|
2021
Q4 | $1.35M | Buy |
300,000
+100,000
| +50% | +$449K | 1.02% | 31 |
|
|
2021
Q3 | $972K | Buy |
200,000
+25,000
| +14% | +$122K | 0.72% | 50 |
|
|
2021
Q2 | $1.19M | Buy |
175,000
+25,000
| +17% | +$171K | 0.86% | 45 |
|
|
2021
Q1 | $1.06M | Buy |
150,000
+115,000
| +329% | +$812K | 0.79% | 52 |
|
|
2020
Q4 | $219K | Buy |
+35,000
| New | +$219K | 0.2% | 74 |
|